Intravoxel incoherent motion diffusion-weighted imaging of pancreatic neuroendocrine tumors: Prediction of the histologic grade using pure diffusion coefficient and tumor size

Investigative Radiology

Volumn 49, Issue 6, 2014, Pages 396-402

  Hwang, Eui Jin ^a   Lee, Jeong Min ^a   Yoon, Jeong Hee ^a   Kim, Jung Hoon ^a   Han, Joon Koo ^a   Choi, Byung Ihn ^a   Lee, Kyoung Bun ^a   Jang, Jin Young ^a   Kim, Sun Whe ^a   Nickel, Marcel Dominik ^b   Kiefer, Berthold ^b  

^a Seoul National University College of Medicine   (South Korea)

^b SIEMENS AG   (Germany)

Author keywords

IVIM; magnetic resonance imaging; neuroendocrine tumor; pancreas

Indexed keywords

GADOBUTROL; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; PANCREATIC NEUROENDOCRINE TUMOR; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PROCEDURES; RETROSPECTIVE STUDY;

ADULT; AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 84900475382     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0000000000000028     Document Type: Article

References (50)

1. Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology. 2008;135:1469-1492.
2. Yao JC, Hassan M, Phan A, et al. One hundred years after ''carcinoid'': epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in the United States. J Clinic Oncol. 2008;26:3063-3072.
3. Burns WR, Edil BH. Neuroendocrine pancreatic tumors: guidelines for management and update. Curr Treat Options Oncol. 2012;13:24-34.
4. Minter RM, Simeone DM. Contemporary management of nonfunctioning pancreatic neuroendocrine tumors. J Gastrointest Surg. 2012;16:435-446.
5. Zhou C, Zhang J, Zheng Y, et al. Pancreatic neuroendocrine tumors: a comprehensive review. Int J Cancer. 2012;131:1013-1022.
6. Bosman FT. World Health Organization., International Agency for Research on Cancer. WHO Classification Of Tumours Of The Digestive System. 4th ed. Lyon, France: International Agency for Research on Cancer; 2010.
7. Ballian N, Loeffler AG, Rajamanickam V, et al. A simplified prognostic system for resected pancreatic neuroendocrine neoplasms. HPB (Oxford). 2009;11: 422-428.
8. Oberg K. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches. Curr Opin Oncol. 2012; 24:433-440.
9. Charles-Edwards EM, deSouza NM. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging. 2006;6:135-143.
10. Thoeny HC, Ross BD. Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J Magn Reson Imaging. 2010;32:2-16.
11. Parikh T, Drew SJ, Lee VS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology. 2008;246:812-822.
12. Schnapauff D, Zeile M, Niederhagen MB, et al. Diffusion-weighted echo-planar magnetic resonance imaging for the assessment of tumor cellularity in patients with soft-tissue sarcomas. J Magn Reson Imaging. 2009;29: 1355-1359.
13. Higano S, Yun X, Kumabe T, et al. Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology. 2006;241:839-846.
14. Muhi A, Ichikawa T, Motosugi U, et al. High-b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of he-patocellular carcinoma. J Magn Reson Imaging. 2009;30:1005-1011.
15. Wang Y, Chen ZE, Yaghmai V, et al. Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics. J Magn Reson Imaging. 2011;33:1071-1079.
16. DeLellis RA. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004.
17. Le Bihan D, Breton E, Lallemand D, et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168:497-505.
18. Le Bihan D, Turner R, Moonen CT, et al. Imaging of diffusion and microcirculation with gradient sensitization: design, strategy, and significance. J Magn Reson Imaging. 1991;1:7-28.
19. LeBihan D. IVIM method measures diffusion and perfusion. Diagn Imaging. 1990;12:133, 136.
20. Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161:401-407.
21. Koh DM, Collins DJ, Orton MR. Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol. 2011; 196:1351-1361.
22. Dumortier J, Ratineau C, Roche C, et al. Angiogenesis and endocrine tumors [in French]. Bull Cancer. 1999;86:148-153.
23. Procacci C, Carbognin G, Accordini S, et al. Nonfunctioning endocrine tumors of the pancreas: possibilities of spiral CT characterization. Eur Radiol. 2001;11:1175-1183.
24. Stafford Johnson DB, Francis IR, Eckhauser FE, et al. Dual-phase helical CT of nonfunctioning islet cell tumors. J Comput Assist Tomog. 1998;22:59-63.
25. Klauss M, Lemke A, Grunberg K, et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Invest Radiol. 2011;46:57-63.
26. Lemke A, Laun FB, Klauss M, et al. Differentiation of pancreas carcinoma from healthy pancreatic tissue using multiple b-values: comparison of apparent diffusion coefficient and intravoxel incoherent motion derived parameters. Invest Radiol. 2009;44:769-775.
27. Binser T, Thoeny HC, Eisenberger U, et al. Comparison of physiological triggering schemes for diffusion-weighted magnetic resonance imaging in kidneys. J Magn Reson Imaging. 2010;31:1144-1150.
28. Wick MR, Graeme-Cook FM. Pancreatic neuroendocrine neoplasms: a current summary of diagnostic, prognostic, and differential diagnostic information. Am J Clin Pathol. 2001;115(suppl):S28-S45.
29. La Rosa S, Klersy C, Uccella S, et al. Improved histologic and clinicopatho-logic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol. 2009;40:30-40.
30. Klimstra DS, Modlin IR, Adsay NV, et al. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol. 2010;34:300-313.
31. Klimstra DS, Modlin IR, Coppola D, et al. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas. 2010;39:707-712.
32. Gibbs P, Liney GP, Pickles MD, et al. Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Invest Radiol. 2009; 44:572-576.
33. Ginat DT, Mangla R, Yeaney G, et al. Diffusion-weighted imaging for differentiating benign from malignant skull lesions and correlation with cell density. AJR Am J Roentgenol. 2012;198:W597-W601.
34. Hayashida Y, Hirai T, Morishita S, et al. Diffusion-weighted imaging of met-astatic brain tumors: comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol. 2006;27:1419-1425.
35. Chandarana H, Lee VS, Hecht E, et al. Comparison of biexponential and monoexponential model of diffusion weighted imaging in evaluation of renal lesions: preliminary experience. Invest Radiol. 2011;46:285-291.
36. Sellner F, Thalhammer S, Stattner S, et al. TNM stage and grade in predicting the prognosis of operated, non-functioning neuroendocrine carcinoma of the pancreasVa single-institution experience. J Surg Oncol. 2011;104:17-21.
37. Wang DS, Zhang DS, Qiu MZ, et al. Prognostic factors and survival in patients with neuroendocrine tumors of the pancreas. Tumour Biol. 2011;32:697-705.
38. Kloppel G. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer. 2011;18(suppl 1):S1-S16.
39. Malayeri AA, El Khouli RH, Zaheer A, et al. Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up. Radiographics. 2011;31:1773-1791.
40. Nakanishi M, Chuma M, Hige S, et al. Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of he-patocellular carcinoma. Ann Surg Oncol. 2012;19:1302-1309.
41. An C, Park MS, Jeon HM, et al. Prediction of the histopathological grade of hepatocellular carcinoma using qualitative diffusion-weighted, dynamic, and hepatobiliary phase MRI. Eur Radiol. 2012;22:1701-1708.
42. Heo SH, Jeong YY, Shin SS, et al. Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor. Korean J Radiol. 2010;11:295-303.
43. Nasu K, Kuroki Y, Tsukamoto T, et al. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade. AJR Am J Roentgenol. 2009;193:438-444.
44. Nishie A, Tajima T, Asayama Y, et al. Diagnostic performance of apparent diffusion coefficient for predicting histological grade of hepatocellular carcinoma. Eur J Radiol. 2011;80:e29-e33.
45. d'Assignies G, Couvelard A, Bahrami S, et al. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology. 2009;250:407-416.
46. Semelka RC, Custodio CM, Cem Balci N, et al. Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. J Magn Reson Imaging. 2000; 11:141-148.
47. Marion-Audibert AM, Barel C, Gouysse G, et al. Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroen-terology. 2003;125:1094-1104.
48. Takahashi Y, Akishima-Fukasawa Y, Kobayashi N, et al. Prognostic value of tumor architecture, tumor-associated vascular characteristics, and expression of angiogenic molecules in pancreatic endocrine tumors. Clin Cancer Res. 2007;13:187-196.
49. Haugvik SP, Marangos IP, Rosok BI, et al. Long-term outcome of laparoscopic surgery for pancreatic neuroendocrine tumors. World J Surg. 2013;37:582-590.
50. Lemke A, Laun FB, Simon D, et al. An in vivo verification of the intravoxel incoherent motion effect in diffusion-weighted imaging of the abdomen. Magn Reson Med. 2010;64:1580-1585.